Genovefa Papanicolaou

8PUBLICATIONS
36CO-AUTHORS
Disease surveillanceInnate immunityHaematologyPreventative health careCellular immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Dec 01, 2025
An Analysis of Cytomegalovirus-Specific Cell-Mediated Immunity in a Phase 3, Randomized, Placebo-Controlled Trial of Letermovir Prophylaxis in Cytomegalovirus-Seropositive Recipients of an Allogeneic Hematopoietic Cell Transplant.

Genovefa A Papanicolaou, Sanjeet S Dadwal, Ella J Ariza-Heredia

|Jan 29, 2025
Refractory and Resistant Herpes Simplex Virus Mucocutaneous Infections in Immunocompromised Patients: Literature Review and Proposed Definitions for Use in Clinical Trials.

Roy F Chemaly, Tali Shafat, Anna Wald

|Oct 31, 2023
Post-transplantation cyclophosphamide is associated with increased bacterial infections.

Celalettin Ustun, Min Chen, Soyoung Kim

|Oct 21, 2023
CMV prevention strategies in allogeneic hematopoietic cell transplantation; the role of prophylaxis and pre-emptive monitoring in the era of letermovir.

Michelle K Yong, Monica A Slavin, Roy F Chemaly

|May 17, 2023
Emergence of human CMV-induced NKG2C+ NK cells is associated with CD8+ T-cell recovery after allogeneic HCT.

Kattria van der Ploeg, Rosa Sottile, Theodota Kontopoulos

Pageof 2